Deric Park to Brain Neoplasms
This is a "connection" page, showing publications Deric Park has written about Brain Neoplasms.
Connection Strength
3.332
-
Mitochondrial NIX Promotes Tumor Survival in the Hypoxic Niche of Glioblastoma. Cancer Res. 2019 10 15; 79(20):5218-5232.
Score: 0.436
-
Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells. Neuro Oncol. 2017 Jul 01; 19(7):887-896.
Score: 0.375
-
Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma. J Neurooncol. 2016 12; 130(3):571-579.
Score: 0.359
-
The evidence of glioblastoma heterogeneity. Sci Rep. 2015 Jan 27; 5:7979.
Score: 0.317
-
Trans sodium crocetinate: functional neuroimaging studies in a hypoxic brain tumor. J Neurosurg. 2011 Oct; 115(4):749-53.
Score: 0.247
-
Improving the radiosensitivity of radioresistant and hypoxic glioblastoma. Future Oncol. 2010 Oct; 6(10):1591-601.
Score: 0.235
-
Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene. 2009 Nov 12; 28(45):3949-59.
Score: 0.218
-
Biology of glioma cancer stem cells. Mol Cells. 2009 Jul 31; 28(1):7-12.
Score: 0.216
-
N-CoR pathway targeting induces glioblastoma derived cancer stem cell differentiation. Cell Cycle. 2007 Feb 15; 6(4):467-70.
Score: 0.183
-
Pharmacotherapy of primary CNS lymphoma. Expert Opin Pharmacother. 2002 Jan; 3(1):39-49.
Score: 0.128
-
Pediatric Gliomas Presenting with Gliomatosis-Like Spread, Lack of Contrast Enhancement, EGFR Mutation, and TERT Promoter Variants. J Neuropathol Exp Neurol. 2021 12 29; 80(12):1134-1136.
Score: 0.128
-
Asymptomatic brainstem lesions and pachymeningeal enhancement after anti-PD-1 therapy. Immunotherapy. 2021 01; 13(1):11-17.
Score: 0.118
-
Cytokine Microdialysis for Real-Time Immune Monitoring in Glioblastoma Patients Undergoing Checkpoint Blockade. Neurosurgery. 2019 04 01; 84(4):945-953.
Score: 0.106
-
Clinical decision making in the era of immunotherapy for high grade-glioma: report of four cases. BMC Cancer. 2018 03 01; 18(1):239.
Score: 0.098
-
CNTF receptor subunit a as a marker for glioma tumor-initiating cells and tumor grade: laboratory investigation. J Neurosurg. 2012 Dec; 117(6):1022-1031.
Score: 0.068
-
The effect of a PP2A inhibitor on the nuclear receptor corepressor pathway in glioma. J Neurosurg. 2010 Aug; 113(2):225-33.
Score: 0.058
-
Proteomic profiling distinguishes astrocytomas and identifies differential tumor markers. Neurology. 2006 Mar 14; 66(5):733-6.
Score: 0.043